Target- |
Mechanism- |
|
Originator Org.- |
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1996 |
Target- |
Mechanism- |
Active Org.- |
Originator Org.- |
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
济脉通片与安慰剂平行对照治疗高血压(肝火亢盛证)随机、双盲、多中心Ⅱ期临床试验
[Translation] A randomized, double-blind, multicenter phase II clinical trial of Jimaitong tablets versus placebo in the treatment of hypertension (liver fire hyperactivity syndrome)
初步评价济脉通片治疗高血压(肝火亢盛证)在降低血压,改善症状等方面的有效性和安全性。
[Translation] To preliminarily evaluate the effectiveness and safety of Jimaitong tablets in the treatment of hypertension (liver fire hyperactivity syndrome) in terms of lowering blood pressure and improving symptoms.
100 Clinical Results associated with Chimin Health Management Co., Ltd.
0 Patents (Medical) associated with Chimin Health Management Co., Ltd.
100 Deals associated with Chimin Health Management Co., Ltd.
100 Translational Medicine associated with Chimin Health Management Co., Ltd.